Stock Market & Financial Investment News

News Breaks January 22, 2013 09:18 EDT PCYC, JNJ Pharmacyclics price target raised to $80 from $65 at Roth Capital Roth Capital expects Pharmacyclics (PCYC) to benefit from the launch of its partnership with Johnson & Johnson (JNJ), and its plans to expand its ibrutinib drug into the treatment of new indications. The firm maintains a Buy rating on the stock. News For PCYC;JNJ From The Last 14 Days Check below for free stories on PCYC;JNJ the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 24, 2013 07:54 EDT JNJ Johnson & Johnson drug business should maintain momentum, says Wells Fargo After attending J&J's bi-annual pharmaceutical business review, Wells Fargo believes that the revenue generated by four of the company's new drugs could double from 2012 to 2015. The firm thinks the company's pharmaceutical unit has one of the best growth outlooks in the sector, and it keeps an Outperform rating on the stock. 06:28 EDT JNJ Johnson & Johnson price target raised to $94 from $88 at Leerink Subscribe for More Information May 23, 2013 10:08 EDT JNJ On The Fly: Analyst Initiation Summary Subscribe for More Information 07:31 EDT JNJ Janssen expects to have more than 25 brand line extensions by 2017 Subscribe for More Information 06:29 EDT JNJ Johnson & Johnson coverage assumed with an Underperform at Credit Suisse Subscribe for More Information May 22, 2013 16:00 EDT JNJ Options Update; May 22, 2013 Subscribe for More Information May 21, 2013 07:24 EDT JNJ Global Health Care to host a conference Subscribe for More Information May 20, 2013 14:07 EDT PCYC Pharmacyclics drug designated for orphan status for multiple myeloma treatment Subscribe for More Information May 17, 2013 06:19 EDT JNJ J&J to end sales of of metal-on-metal hip replacements, Bloomberg reports Subscribe for More Information May 15, 2013 16:51 EDT JNJ FDA approves Simponi to treat ulcerative colitis Subscribe for More Information May 13, 2013 10:09 EDT PCYC On The Fly: Analyst Upgrade Summary Subscribe for More Information 06:33 EDT PCYC Pharmacyclics upgraded to Outperform from Sector Perform at RBC Capital Subscribe for More Information May 10, 2013 11:48 EDT JNJ Drugmakers to face pressure on U.S. prices, Reuters says Subscribe for More Information 06:16 EDT JNJ Obesity surgery booming in India, Bloomberg reports Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.